Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00BPA
|
|||
| Former ID |
DNC001057
|
|||
| Drug Name |
Olomoucine
|
|||
| Synonyms |
olomoucine; 101622-51-9; 4erk; UNII-6A839B2HYS; 2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine; 6A839B2HYS; CHEMBL280074; 2-{[6-(benzylamino)-9-methyl-9h-purin-2-yl]amino}ethanol; 6-Benzylamino-2-(2-hydroxyethylamino)-9-methylpurine; 6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine; Ethanol,2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-; OLO; 2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine; 6-Benylamino-2-(2-hydroxyethylamino)-9-methylpurine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H18N6O
|
|||
| Canonical SMILES |
CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3
|
|||
| InChI |
1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20)
|
|||
| InChIKey |
GTVPOLSIJWJJNY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 101622-51-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
511554, 585538, 602815, 3153144, 4696240, 7889577, 8035333, 8152817, 11111567, 11114014, 11120217, 11120705, 11121193, 11121680, 11122160, 11147300, 11362744, 11365306, 11367868, 11370759, 11370760, 11373469, 11376030, 11427271, 12078031, 14776023, 17405442, 22391549, 24278053, 26681496, 26718907, 26752151, 26752152, 26752153, 26759291, 26759294, 29223681, 46394384, 46488044, 46508610, 47588772, 47959482, 47959483, 47959484, 48110223, 48184764, 48184765, 50104796, 50104797, 50104798
|
|||
| ChEBI ID |
CHEBI:44661
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor. Cell Mol Life Sci. 2005 Aug;62(15):1763-71. | |||
| REF 2 | Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci. 2002 Sep;23(9):417-25. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.